# WWP1 gain-of-function drives developmental anoikis through TGFβ pathway during neurodevelopment

**Authors:** Ki Hurn So, Seungbok Lee, Jiayi Wong, Hyunsik Lee, Eun-Jin Yun, Se Song Jang, Hee-Jung Choi, Jong-Hee Chae, Seung Tae Baek

PMC · DOI: 10.1038/s41420-026-02977-4 · Cell Death Discovery · 2026-03-06

## TL;DR

This study shows that overactive WWP1 causes brain development issues in mice and humans by disrupting cell adhesion and TGFβ signaling.

## Contribution

The study identifies WWP1 gain-of-function as a driver of neurodevelopmental defects through TGFβ pathway downregulation.

## Key findings

- WWP1 gain-of-function causes impaired neuronal migration and cell death in mouse and human models.
- TGFβ1 treatment rescues cell survival in WWP1 hyperactivity-induced neurodevelopmental defects.
- A de novo WWP1 variant in a patient with encephalopathy is characterized as gain-of-function.

## Abstract

The E3 ubiquitin ligase WWP1 orchestrates multiple cellular functions, yet the neurodevelopmental role and pathological implications of its dysregulation remain poorly defined, in contrast to its established oncogenic effects. Here, we demonstrate that hyperactive WWP1 induces neurodevelopmental abnormalities characterized by impaired neuronal migration and caspase-dependent cell death in the developing mouse brain and human neural progenitor cell models. Mechanistically, WWP1 gain-of-function (GOF) mutation disrupts cell adhesion, leading to anoikis, detachment-induced cell death. Pathway-level screening identifies TGFβ1 ligand treatment to restore cell survival in both neural progenitor cultures and embryonic mouse brains. Conversely, TGFβ pathway inhibition phenocopies WWP1-induced apoptosis, establishing that WWP1 hyperactivity promotes cell death via TGFβ pathway downregulation. Transcriptomic profiling of the WWP1 GOF cellular models confirms the downregulation of cell adhesion and TGFβ signaling pathway signatures, highlighting the necessity of balanced WWP1 activity during neurodevelopment. In addition, we identified a de novo WWP1 variant in a patient with developmental and epileptic encephalopathy. Biochemical and in vivo functional analyses characterize the variant as GOF, supporting the clinical relevance of WWP1 dysregulation in neurodevelopmental disorders. Together, these findings reveal WWP1 as a critical regulator of neuronal survival and adhesion, with its dysregulation disrupting key developmental processes in the human brain.

## Linked entities

- **Genes:** WWP1 (WW domain containing E3 ubiquitin protein ligase 1) [NCBI Gene 11059], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040]
- **Diseases:** developmental and epileptic encephalopathy (MONDO:0100062)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, WWP1 (WW domain containing E3 ubiquitin protein ligase 1) [NCBI Gene 11059] {aka AIP5, Tiul1, hSDRP1}
- **Diseases:** neurodevelopmental disorders (MESH:D002658), developmental and epileptic encephalopathy (MESH:C562695), neurodevelopmental abnormalities (MESH:D063647)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039840/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039840/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC13039840/full.md

---
Source: https://tomesphere.com/paper/PMC13039840